Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.
Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Cognitive impairment and cortical degeneration in neuromyelitis optica.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
[Central motor pathways in children with multiple sclerosis].
The refinement of genetic predictors of multiple sclerosis.
Is natalizumab overshooting its rebound?
Multiple sclerosis.
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study.
Neuromyelitis optica: clinical manifestations and neuroimaging features.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.

Pages